表紙
市場調查報告書

抗高血壓藥的全球市場

Anti-Hypertensive Drugs

出版商 Global Industry Analysts, Inc. 商品編碼 912666
出版日期 內容資訊 英文 162 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
抗高血壓藥的全球市場 Anti-Hypertensive Drugs
出版日期: 2019年10月01日內容資訊: 英文 162 Pages
簡介

本報告提供全球抗高血壓藥的市場相關分析,彙整整體市場規模的實際成果值·預測值,及主要推動及阻礙市場要素,各類型及各企業的市場佔有率趨勢 (過去9年·今後8年份),今後的市場成長的方向性,各地區·主要國家的市場詳細趨勢等調查,主要企業的簡介等資訊,為您概述為以下內容。

第1章 分析方法

第2章 摘要整理

  • 市場概要
    • 各企業的市場佔有率結構 (最新值·預測值)
  • 代表性企業分析
  • 市場趨勢與促進因素
  • 全球市場的未來展望
    • 市場規模·佔有率趨勢預測:各地區/各國
    • 各類型
      • 利尿劑
      • ACE (血管收縮素轉化酵素) 抑制劑
      • ABR (血管收縮素II受體拮抗劑)
      • 鈣拮抗劑
      • β/Alpha阻斷劑
      • 其他

第3章 市場分析

  • 各地區的市場分析
  • 美國
    • 市場基本資料
    • 各企業市場佔有率
    • 抗高血壓藥的市場規模 (實際成果值·預測值)
    • 不同種類的市場規模 (實際成果值·預測值)
  • 加拿大
  • 日本
  • 中國
  • 歐洲 (法國,德國,義大利,英國,西班牙,俄羅斯等)
  • 亞太地區 (澳洲,印度,韓國等)
  • 南美 (阿根廷,巴西,墨西哥等)
  • 中東 (伊朗,以色列,沙烏地阿拉伯,UAE等)
  • 非洲

第4章 企業

  • ACTELION PHARMACEUTICALS LTD.
  • AMNEAL PHARMACEUTICALS
  • Astellas Pharma Inc.
  • ASTRAZENECA PLC
  • BAYER AG
  • AUROBINDO PHARMA
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • CHIESI FARMACEUTICI SPA
  • CHINA PHARMA HOLDINGS
  • CIPLA
  • 第一三共
  • DR. REDDY'S LABORATORIES LTD.
  • GILEAD SCIENCES, INC.
  • GLAXOSMITHKLINE PLC
  • GLENMARK PHARMACEUTICALS
  • LEXICON PHARMACEUTICALS
  • JOHNSON & JOHNSON
  • LUPIN PHARMACEUTICALS, INC.
  • MERCK & CO., INC.
  • NOVARTIS AG
  • NOVARTIS INTERNATIONAL AG
  • NOVARTIS PHARMACEUTICALS CORPORATION
  • PFIZER, INC
  • RECORDATI SPA
  • SANOFI
  • 鹽野義製藥
  • 武田藥品工業
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • TORAY

第5章 相關分析

目錄
Product Code: MCP-6021

Anti-Hypertensive Drugs market worldwide is projected to grow by US$3.6 Billion, driven by a compounded growth of 1.5%. Diuretics, one of the segments analyzed and sized in this study, displays the potential to grow at over 1.9%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$11 Billion by the year 2025, Diuretics will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 1.2% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$152.9 Million to the region's size and clout in the next 5 to 6 years. Over US$111.3 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Diuretics will reach a market size of US$588.4 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 2.3% over the next couple of years and add approximately US$946.6 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, Actelion Pharmaceuticals Ltd.; AstraZeneca PLC; Bayer AG; Boehringer Ingelheim GmbH; Daiichi Sankyo Co., Ltd.; Johnson & Johnson; Lupin Pharmaceuticals, Inc.; Merck & Co., Inc.; Novartis International AG; Pfizer, Inc.; Sanofi; Takeda Pharmaceutical Co., Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Anti-Hypertensive Drugs Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Anti-Hypertensive Drugs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Anti-Hypertensive Drugs Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Anti-Hypertensive Drugs Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Diuretics (Type) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Diuretics (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Diuretics (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: ACE Inhibitors (Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: ACE Inhibitors (Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: ACE Inhibitors (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: ARBs (Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 11: ARBs (Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 12: ARBs (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Calcium Channel Blockers (Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 14: Calcium Channel Blockers (Type) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 15: Calcium Channel Blockers (Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Beta & Alpha - Adrenergic Blocker (Type) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 17: Beta & Alpha - Adrenergic Blocker (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 18: Beta & Alpha - Adrenergic Blocker (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 19: Other Types (Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025
  • TABLE 20: Other Types (Type) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 21: Other Types (Type) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Anti-Hypertensive Drugs Market Share (in %) by Company: 2019 & 2025
    • TABLE 22: United States Anti-Hypertensive Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 23: Anti-Hypertensive Drugs Market in the United States by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 24: United States Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 25: Canadian Anti-Hypertensive Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 26: Canadian Anti-Hypertensive Drugs Historic Market Review by Type in US$ Million: 2009-2017
    • TABLE 27: Anti-Hypertensive Drugs Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
  • JAPAN
    • TABLE 28: Japanese Market for Anti-Hypertensive Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 29: Anti-Hypertensive Drugs Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 30: Japanese Anti-Hypertensive Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 31: Chinese Anti-Hypertensive Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 32: Anti-Hypertensive Drugs Historic Market Analysis in China in US$ Million by Type: 2009-2017
    • TABLE 33: Chinese Anti-Hypertensive Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Anti-Hypertensive Drugs Market: Competitor Market Share Scenario (in %)
    • for 2019 & 2025
    • TABLE 34: European Anti-Hypertensive Drugs Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 35: Anti-Hypertensive Drugs Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 36: European Anti-Hypertensive Drugs Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 37: European Anti-Hypertensive Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 38: Anti-Hypertensive Drugs Market in Europe in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 39: European Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 40: Anti-Hypertensive Drugs Market in France by Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 41: French Anti-Hypertensive Drugs Historic Market Scenario in US$ Million by Type: 2009-2017
    • TABLE 42: French Anti-Hypertensive Drugs Market Share Analysis by Type:
  • 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 43: Anti-Hypertensive Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 44: German Anti-Hypertensive Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 45: German Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 46: Italian Anti-Hypertensive Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 47: Anti-Hypertensive Drugs Historic Market Analysis in Italy in US$ Million by Type: 2009-2017
    • TABLE 48: Italian Anti-Hypertensive Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 49: United Kingdom Market for Anti-Hypertensive Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 50: Anti-Hypertensive Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 51: United Kingdom Anti-Hypertensive Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 52: Spanish Anti-Hypertensive Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 53: Spanish Anti-Hypertensive Drugs Historic Market Review by Type in US$ Million: 2009-2017
    • TABLE 54: Anti-Hypertensive Drugs Market in Spain: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 55: Russian Anti-Hypertensive Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 56: Anti-Hypertensive Drugs Market in Russia by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 57: Russian Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 58: Rest of Europe Anti-Hypertensive Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 59: Anti-Hypertensive Drugs Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 60: Rest of Europe Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 61: Asia-Pacific Anti-Hypertensive Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 62: Anti-Hypertensive Drugs Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 63: Asia-Pacific Anti-Hypertensive Drugs Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 64: Anti-Hypertensive Drugs Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 65: Asia-Pacific Anti-Hypertensive Drugs Historic Market Scenario in US$ Million by Type: 2009-2017
    • TABLE 66: Asia-Pacific Anti-Hypertensive Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 67: Anti-Hypertensive Drugs Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 68: Australian Anti-Hypertensive Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 69: Australian Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 70: Indian Anti-Hypertensive Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 71: Indian Anti-Hypertensive Drugs Historic Market Review by Type in US$ Million: 2009-2017
    • TABLE 72: Anti-Hypertensive Drugs Market in India: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 73: Anti-Hypertensive Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 74: South Korean Anti-Hypertensive Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 75: Anti-Hypertensive Drugs Market Share Distribution in South Korea by Type: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 76: Rest of Asia-Pacific Market for Anti-Hypertensive Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 77: Anti-Hypertensive Drugs Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 78: Rest of Asia-Pacific Anti-Hypertensive Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 79: Latin American Anti-Hypertensive Drugs Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 80: Anti-Hypertensive Drugs Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 81: Latin American Anti-Hypertensive Drugs Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 82: Latin American Anti-Hypertensive Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 83: Anti-Hypertensive Drugs Historic Market Analysis in Latin America in US$ Million by Type: 2009-2017
    • TABLE 84: Latin American Anti-Hypertensive Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 85: Argentinean Anti-Hypertensive Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 86: Anti-Hypertensive Drugs Market in Argentina in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 87: Argentinean Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 88: Anti-Hypertensive Drugs Market in Brazil by Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 89: Brazilian Anti-Hypertensive Drugs Historic Market Scenario in US$ Million by Type: 2009-2017
    • TABLE 90: Brazilian Anti-Hypertensive Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 91: Anti-Hypertensive Drugs Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 92: Mexican Anti-Hypertensive Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 93: Mexican Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 94: Rest of Latin America Anti-Hypertensive Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 95: Anti-Hypertensive Drugs Market in Rest of Latin America by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 96: Rest of Latin America Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 97: The Middle East Anti-Hypertensive Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 98: Anti-Hypertensive Drugs Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 99: The Middle East Anti-Hypertensive Drugs Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 100: The Middle East Anti-Hypertensive Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 101: The Middle East Anti-Hypertensive Drugs Historic Market by Type in US$ Million: 2009-2017
    • TABLE 102: Anti-Hypertensive Drugs Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
  • IRAN
    • TABLE 103: Iranian Market for Anti-Hypertensive Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 104: Anti-Hypertensive Drugs Market in Iran: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 105: Iranian Anti-Hypertensive Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 106: Israeli Anti-Hypertensive Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 107: Anti-Hypertensive Drugs Market in Israel in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 108: Israeli Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 109: Saudi Arabian Anti-Hypertensive Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 110: Anti-Hypertensive Drugs Historic Market Analysis in Saudi Arabia in US$ Million by Type: 2009-2017
    • TABLE 111: Saudi Arabian Anti-Hypertensive Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 112: Anti-Hypertensive Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 113: United Arab Emirates Anti-Hypertensive Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 114: Anti-Hypertensive Drugs Market Share Distribution in United Arab Emirates by Type: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 115: Anti-Hypertensive Drugs Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 116: Rest of Middle East Anti-Hypertensive Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 117: Rest of Middle East Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 118: African Anti-Hypertensive Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 119: Anti-Hypertensive Drugs Market in Africa by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 120: African Anti-Hypertensive Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025

IV. COMPETITION

  • ACTELION PHARMACEUTICALS LTD.
  • AMNEAL PHARMACEUTICALS
  • ASTELLAS PHARMA, INC.
  • ASTRAZENECA PLC
  • BAYER AG
  • AUROBINDO PHARMA
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • CHIESI FARMACEUTICI SPA
  • CHINA PHARMA HOLDINGS
  • CIPLA
  • DAIICHI SANKYO CO., LTD.
  • DR. REDDY'S LABORATORIES LTD.
  • GILEAD SCIENCES, INC.
  • GLAXOSMITHKLINE PLC
  • GLENMARK PHARMACEUTICALS
  • LEXICON PHARMACEUTICALS
  • JOHNSON & JOHNSON
  • LUPIN PHARMACEUTICALS, INC.
  • MERCK & CO., INC.
  • NOVARTIS AG
  • NOVARTIS INTERNATIONAL AG
  • NOVARTIS PHARMACEUTICALS CORPORATION
  • PFIZER, INC
  • RECORDATI SPA
  • SANOFI
  • SHIONOGI & CO., LTD.
  • TAKEDA PHARMACEUTICAL COMPANY LIMITED
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • TORAY INDUSTRIES, INC

V. CURATED RESEARCH

Back to Top